Article Versions Notes

Bähr S, Rue RW, Smith CJ, Evans JF, Köster H, Krymskaya VP, Pleimes D. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules. 2024; 14(10):1236. https://doi.org/10.3390/biom14101236

Bähr, Stella, Ryan W. Rue, Carly J. Smith, Jillian F. Evans, Hubert Köster, Vera P. Krymskaya, and Dirk Pleimes. 2024. "Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis" Biomolecules 14, no. 10: 1236. https://doi.org/10.3390/biom14101236

Bähr, S., Rue, R. W., Smith, C. J., Evans, J. F., Köster, H., Krymskaya, V. P., & Pleimes, D. (2024). Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules, 14(10), 1236. https://doi.org/10.3390/biom14101236